Regressions of established breast carcinoma xenografts by carboxypeptidase G2 suicide gene therapy and the prodrug CMDA are due to a bystander effect

Human Gene Therapy

Volumn 11, Issue 2, 2000, Pages 285-292

  Stribbling, Stephen M ^a   Friedlos, Frank ^a   Martin, Janet ^a   Davies, Lawrence ^a   Spooner, Robert A ^a   Marais, Richard ^a   Springer, Caroline J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDE; GAMMA GLUTAMYL HYDROLASE; N [4 [(2 CHLOROETHYL)(2 MESYLOXYETHYL)AMINO]BENZOYL]GLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; SUICIDE GENE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BODY WEIGHT; BREAST NEOPLASMS; FEMALE; GAMMA-GLUTAMYL HYDROLASE; GENE THERAPY; GLUTAMATES; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NITROGEN MUSTARD COMPOUNDS; PRODRUGS; TIME FACTORS;

EID: 0034688260     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050016021     Document Type: Article

References (40)

1. BI, W.L., PARYSEK, L.M., WARNICK, R., and STAMBROOK, P.J. (1993). In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
2. BI, W., KIM, Y.G., FELICIANO, E.S., PAVELIC, L., WILSON, K.M., PAVELIC, Z.P., and STAMBROOK, P.J. (1997). An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice. Cancer Gene Ther. 4, 246-252.
3. BRIDGEWATER, G., SPRINGER, C.J., KNOX, R., MINTON, N., MICHAEL, P., and COLLINS, M. (1995). Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB 1954. Eur. J. Cancer 31A, 2362-2370.
4. BURT, J.N., and SPRAY, D.C. (1988). Single-channel events and gating behaviour of the cardiac gap junction channel. Proc. Natl. Acad. Sci. U.S.A. 85, 3431-6434.
5. CALABRESI, P., and WELCH, A.D. (1994). Cytotoxic drugs, hormones and radioactive isotopes. In Cytotoxic Drugs, Hormones and Radioactive Isotopes. L.S. Goodman and A. Gilman, eds. (Macmillan, New York) pp. 1345-1393.
6. CARUSO, M., PARIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J.-L., and KLATZMANN, D. (1993). Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. U.S.A. 90, 7024-7028.
7. CHANSON, M., BRUZZONE, R., BOSCO, D., and MEDA, P. (1989). Effects of n-alcohols on junctional coupling and amylase secretion of pancreatic acinar cells. J. Cell Phys. 139, 147-156.
8. DILBER, M.S., ABREDI, M.R., CHRISTENSSON, B., BJORKSTAND, B., KIDDER, G.M., NAUS, C.C.G., GAHRTON, F., and SMITH, C.I.E. (1997). Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo. Cancer Res. 57, 1523-1528.
9. EASTHAM, J.A., CHEN, S.H., SEHGAL, I., YANG, G., TIMME, T.L., HALL, S.J., WOO, S.L.C., and THOMPSON, T.C. (1996). Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum. Gene Ther. 7, 515-523.
10. FREEMAN, S.M., ABOUD, C.N., WHARTENBY, K.A., PACKMAN, C.H., KEOPLIN, D.S., MOOLTEN, F.S., and ABRAHAM, G.N. (1993). The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res. 53, 5274-5283.
11. GAGANDEEP, S., BREW, R., GREEN, B., CHRISTMAS, S.E., KLATZMANN, D., POSTON, G.J., and KINSELLA, A.R. (1996). Prodrug-activated gene therapy: Involvement of an immunological component in the "bystander effect." Cancer Gene. Ther. 3, 83-88.
12. HUBER, B.E., RICHARDS, C.A., and KRENISTSKY, T.A. (1991). Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 88, 8039-8043.
13. HUBER, B.E., AUSTIN, E.A., RICHARDS, C.A., DAVIS, S.T., and GOOD, S.S. (1994). Metabolism of 5-fluorocytidine in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc. Natl. Acad. Sci. U.S.A. 91, 8302-8306.
14. HUGHES, B.W., WELLS, A.H., BEBOK, A.H., GADI, V.K., GARVER, R.I., PARKER, W.B., and SORSCHER, E.J. (1995). Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res. 55, 3339-3345.
15. MANOME, Y., WEN, P.Y., DONG, Y., TONAKA, T., MITCHELL, B.S., KUGE, D.A., and FINE, H.A. (1996). Viral vector transduction of the human deoxycytidine kinase cDNA sensitises glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nature Med. 2, 567-573.
16. MARAIS, S., SPOONER, R.A., LIGHT, Y., MARTIN, J., and SPRINGER, C.J. (1996). Gene-directed enzyme prodrug therapy with a mustard prodrug/carboxypeptidase G2 combination. Cancer Res. 56, 4735-4742.
17. MARAIS, R., SPOONER, R.A., STRIBBLING, S.M., LIGHT, Y., MARTIN, J., and SPRINGER, C.J. (1997). A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy. Nature Biotechnol. 15, 1373-1377.
18. MESNIL, M., PICCOLIM, C., TIRABY, G., WILLECKE, K., and YAMASAKI, H. (1996). Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. U.S.A. 93, 1831-1835.
19. MOOLTEN, F.L., VONDERHAAR, B.K., and MROZ, P.J. (1996). Transduction of the herpes thymidine kinase gene into premalignant murine mammary epithelial cells renders subsequent breast cancers responsive to ganciclovir therapy. Hum. Gene Ther. 7, 1197-1204.
20. MULLEN, C.A., KILSTRUP, M., and BLAESE, R.M. (1992). Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc. Natl. Acad. Sci. U.S.A. 89, 33-37.
21. NICULESCU-DUVAZ, I., SPOONER, R., MARAIS, R., and SPRINGER, C.J. (1998). Gene-directed enzyme prodrug therapy. Bioconj. Chem. 9, 4-22.
22. OHWADA, A., HIRSCHOWITZ, E.A., and CRYSTAL, R.G. (1996). Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver. Hum. Gene Ther. 7, 1567-1576.
23. PATTERSON, A.V., ZHANG, H., MOGHADDAM, A., BICKNELL, R., TALBOT, D.C., STRATFORD, I.J., and HARRIS, A.L. (1995). Increased sensitivity to the prodrug 5′-deoxy-5-fluorouridine and modulation of 5-fluoro-2′-deoxywidine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br. J. Cancer 72, 669-675.
24. PAVLOVIC, J., NAWRATH, M., TU, R., HEINICKE, T., and MOELLING, K. (1996). Anti-tumor immunity is involved in the thymidine kinase-mediated killing of tumors induced by activated Ki-ras(G12V). Gene Ther. 3, 635-643.
25. RAINOV, N.G., KRAMM, C.M., ABOODY-GUTERMAN, K., CHASE, M., UEKI, K., LOIUS, D.N., HARSH, G.R., IV, CHIOCCA, E.A., and BREAKEFIELD, X.O. (1996). Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Cancer Gene Ther. 3, 99-106.
26. RAM, Z., CULVER, K.W., WALBRIDGE, S., BLAESE, R.M., and OLDFIELD, E.H. (1993). In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res. 53, 83-88.
27. RAM, Z., CULVER, K.W., OSHIRO, E.M., VIOLA, J.J., DEVROOM, H.L., OTTO, E., LONG, Z., CHIANG, Y., McGARRITY, G.J., MUUL, L.M., KATZ, D., BLAESE, R.M., and OLDFIELD, E.H. (1997). Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med. 3, 1354-1361.
28. RAMESH, R., MARROGI, A.J., MUNSHI, A., ABBOUD, C.N., and FREEMAN, S.M. (1996). In vivo analysis of the "bystander effect": A cytokine cascade. Exp. Hematol. 24, 829-838.
29. ROSENFELD, M.E., WANG, M., SIEGAL, G.P., ALVAREZ, R.D., MIKHEEVA, G., KRASNYKH, V., and CURIEL, D.T. (1996). Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in SCID mouse model of human ovarian carcinoma. J. Mol. Med. 74, 455-462.
30. SHINOURA, N., CHEN, L., WANI, M.A., KIM, Y.G., LARSON, J.J., WARNICK, R.E., SIMON, M.E., MENON, A.G., BI, W.L., and STAMBROOK, P.J. (1996). Protein and messenger RNA expression of connexin43 in astrocytomas : Implications in brain tumor gene therapy. J. Neurosurg. 84, 839-846.
31. SPRINGER, C.J. (1993). CMDA, an antineoplastic prodrug. Drugs Future 18, 212-215.
32. SPRINGER, C.J., ANTONIW, P., BAGSHAWE, K.D., and WILMAN, D.E.V. (1991). Comparison of half-lives and cytotoxicity of N-mesyloxyethyl-and N-chloroethyl-4-amino benzoyl compounds, products of prodrugs in antibody-directed enzyme prodrug therapy (ADEPT). Anticancer Drug Design 6, 467-479.
33. STRIBBLING, S.M., MARTIN, J., PEDLEY, R.B., BODEN, J.A., SHARMA, S.K., and SPRINGER, C.J. (1997). Biodistribution of an antibody-enzyme conjugate for ADEPT in nude mice bearing a human colon adenocarcinoma xenograft. Cancer Chemother. Pharmacol. 40, 277-284.
34. TAMIYA, T., ONO, Y., WEI, M.X., MROZ, P.J., MOOLTEN, F.L., and CHIOCCA, E.A. (1996). Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine. Cancer Gene Ther. 3, 155-162.
35. VILE, R.G., and HART, I. (1993). Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res. 53, 3860-3864.
36. VILE, R.G., NELSON, J.A., CASTLEDEN, S., CHONG, H., and HART, I.R. (1994). Systemic gene therapy of murine melanoma using tissue specific expression of the HSVER gene involves an immune component. Cancer Res. 54, 6228-6234.
37. VRIONIS, F.D., WU, J.K., QI, P., WALTZMAN, M., CHERINGTON, V., and SPRAY, D.C. (1997). The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSVtk) gene is dependent on connexin expression and cell communication via gap junctions. Gene Ther. 4, 577-585.
38. WALLACE, H., CLARKE, A.R., HARRISON, D.J., HOOPER, M.L., and BISHOP, J.O. (1996). Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpes virus thymidine kinase occurs by p53-independent apoptosis. Oncogene 13, 55-61.
39. WU, J.K., CANO, W.G., MEYLAERTS, S.A.G., QI, P., VRIONIS, F., and CHERINGTON, V. (1994). Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35, 1094-1103.
40. ZHANG, W.W., FUJIWARA, T., GRIMM, E.A., and ROTH, J.A. (1995). Advances in cancer gene therapy. Adv. Pharmacol. 12, 289-341.